Market Research Reports and Industry Reports

Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

Summary
 
 GlobalDatas clinical trial report, “Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015"" provides an overview of Respiratory Syncytial Virus (RSV) Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Respiratory Syncytial Virus (RSV) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
 
 The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
 
 *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 
 Scope
 
 - The report provides a snapshot of the global clinical trials landscape
 - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
 - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
 - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
 - The Report provides enrollment trends for the past five years
 - Report provides latest news for the past three months
 
 *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 
 Reasons to buy

 - Assists in formulating key business strategies with regards to investment
 - Helps in identifying prominent locations for conducting clinical trials which saves time and cost
 - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
 - Supports understanding of trials count and enrollment trends by country in global therapeutics market
 - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
 - Facilitates clinical trial assessment of the indication on a global, regional and country level
 
 *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 Table of Contents 2
 List of Tables 4
 List of Figures 5
 Introduction 7
 Respiratory Syncytial Virus (RSV) Infections 7
 Report Guidance 7
 Clinical Trials by Region 8
 Clinical Trials and Average Enrollment by Country 9
 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
 Top Five Countries Contributing to Clinical Trials in Europe 12
 Top Countries Contributing to Clinical Trials in North America 13
 Top Countries Contributing to Clinical Trials in Middle East and Africa 14
 Top Five Countries Contributing to Clinical Trials in Central and South America 15
 Clinical Trials by G7 Countries: Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials 16
 Clinical Trials by Phase in G7 Countries 17
 Clinical Trials in G7 Countries by Trial Status 18
 Clinical Trials by E7 Countries: Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials 19
 Clinical Trials by Phase in E7 Countries 20
 Clinical Trials in E7 Countries by Trial Status 21
 Clinical Trials by Phase 22
 In Progress Trials by Phase 23
 Clinical Trials by Trial Status 24
 Clinical Trials by End Point Status 25
 Unaccomplished Trials of Respiratory Syncytial Virus (RSV) Infections 26
 Subjects Recruited Over a Period of Time 29
 Clinical Trials by Sponsor Type 30
 Prominent Sponsors 31
 Top Companies Participating in Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials 32
 Prominent Drugs 33
 Latest Clinical Trials News on Respiratory Syncytial Virus (RSV) Infections 34
 Apr 21, 2015: Advanced Inhalation Therapies to Present AIT-RSV Clinical Data at Two Upcoming Medical Meetings 34
 Apr 07, 2015: ADMA Biologics Announces Data to be Presented at the Clinical Immunology Society 2015 Annual Meeting 34
 Clinical Trial Profiles 35
 Clinical Trial Overview of Top Companies 35
 AstraZeneca Plc 35
 Clinical Trial Overview of AstraZeneca Plc 35
 Novavax, Inc. 38
 Clinical Trial Overview of Novavax, Inc. 38
 Johnson & Johnson 39
 Clinical Trial Overview of Johnson & Johnson 39
 Gilead Sciences, Inc. 40
 Clinical Trial Overview of Gilead Sciences, Inc. 40
 GlaxoSmithKline Plc 41
 Clinical Trial Overview of GlaxoSmithKline Plc 41
 AbbVie Inc. 42
 Clinical Trial Overview of AbbVie Inc. 42
 Alnylam Pharmaceuticals, Inc. 43
 Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 43
 Ablynx NV 44
 Clinical Trial Overview of Ablynx NV 44
 Abbott Laboratories 45
 Clinical Trial Overview of Abbott Laboratories 45
 Novartis AG 46
 Clinical Trial Overview of Novartis AG 46
 Clinical Trial Overview of Top Institutes / Government 47
 The National Institute of Allergy and Infectious Diseases 47
 Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 47
 Fred Hutchinson Cancer Research Center 48
 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 48
 Rambam Health Care Campus 49
 Clinical Trial Overview of Rambam Health Care Campus 49
 VU University Medical Center 50
 Clinical Trial Overview of VU University Medical Center 50
 Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 51
 Clinical Trial Overview of Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 51
 Chinese University of Hong Kong 52
 Clinical Trial Overview of Chinese University of Hong Kong 52
 Hurley Medical Center 53
 Clinical Trial Overview of Hurley Medical Center 53
 Memorial Sloan Kettering Cancer Center 54
 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 54
 National Institute of Infectious Diseases 55
 Clinical Trial Overview of National Institute of Infectious Diseases 55
 Netherlands Asthma Foundation 56
 Clinical Trial Overview of Netherlands Asthma Foundation 56
 Five Key Clinical Profiles 57
 Appendix 99
 Abbreviations 99
 Definitions 99
 Research Methodology 100
 Secondary Research 100
 About GlobalData 101
 Contact Us 101
 Disclaimer 101
 Source 102


List Of Tables

 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Region, 2015* 8
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 11
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 12
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, North America, Top Countries, 2015* 13
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 14
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 15
 Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 16
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
 Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 19
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Phase, 2015* 22
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 23
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Suspended Clinical Trials, 2015* 26
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Terminated Clinical Trials, 2015* 28
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 35
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novavax, Inc., 2015* 38
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 39
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 40
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 41
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 42
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2015* 43
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Ablynx NV, 2015* 44
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 45
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 46
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 47
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 48
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2015* 49
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2015* 50
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi, 2015* 51
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 52
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hurley Medical Center, 2015* 53
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 54
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Infectious Diseases, 2015* 55
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Netherlands Asthma Foundation, 2015* 56


List Of Figures

 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Region (%), 2015* 8
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 11
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 12
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 13
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 14
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 15
 Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 16
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
 Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 19
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015* 22
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 23
 Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
 Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
 GlobalData Methodology 100


Europe Respiratory Protective Equipment(RPE) Market Report 2016

Notes:Sales, means the sales volume of Respiratory Protective Equipment(RPE)Revenue, means the sales value of Respiratory Protective Equipment(RPE)This report studies sales (consumption) of Respiratory Protective Equipment(RPE) in Europe market, especially in

USD 3900View Report

Europe Respiratory Assist Device Market Report 2016

Notes:Sales, means the sales volume of Respiratory Assist DeviceRevenue, means the sales value of Respiratory Assist DeviceThis report studies sales (consumption) of Respiratory Assist Device in Europe market, especially in

USD 3900View Report

Europe Respiratory Disease Market 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Complete report $8,300. DataPack (test volumes, sales forecasts, supplier shares) $5,400.This new 335-page report provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales

USD 8300View Report

OpportunityAnalyzer: Respiratory Syncytial Virus (RSV) – Opportunity Analysis and Forecasts to 2024

Human respiratory syncytial virus (RSV) is an enveloped, single-stranded, negative-sense ribonucleic acid (RNA) pneumovirus belonging to the family of Paramyxoviridae. The virus was discovered in 1956, first as an isolate

USD 10995View Report

Respiratory syncytial virus (RSV) - Epidemiology Forecast To 2023

DelveInsight Respiratory syncytial virus (RSV) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Respiratory syncytial virus (RSV) in seven major markets (US, France, Germany, Italy,

USD 2750View Report

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2016

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2016Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial Virus (RSV) Infections Pipeline Review, H2 2016, provides

USD 2000View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF    $ 2500
  • Site Licence    $ 5000
  • Enterprise Wide Licence    $ 7500
$ 2500

Reports Details

Published Date : Jun 2015
No. of Pages :102
Country :Global
Category :Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment